What is the address of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie?

The registered office of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie is located at Horingstraat 13, 9310 Aalst.

Is Dr. Mulliez, orthopedie - Dr. Denys, geriatrie still active?

Yes. According to the CBE (1 October 2026) Dr. Mulliez, orthopedie - Dr. Denys, geriatrie is active, legal situation “Normale toestand”, started on 1 May 2017.

Is Dr. Mulliez, orthopedie - Dr. Denys, geriatrie registered on Peppol?

Yes, Dr. Mulliez, orthopedie - Dr. Denys, geriatrie is registered on the Peppol network with ID 0208:0674965095.

What is the enterprise number of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie?

The enterprise number of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie is BE0674965095.

When was Dr. Mulliez, orthopedie - Dr. Denys, geriatrie founded?

Dr. Mulliez, orthopedie - Dr. Denys, geriatrie was founded on 1 May 2017.

Who are the directors of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie?

According to the 2025 annual accounts, the directors of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie are: Katrien Denys, Alexander Mulliez.

Is Dr. Mulliez, orthopedie - Dr. Denys, geriatrie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 May 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Mulliez, orthopedie - Dr. Denys, geriatrie make in 2025?

Dr. Mulliez, orthopedie - Dr. Denys, geriatrie posted a profit after taxes of € 472,460 in financial year 2025.

What is the revenue of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie?

As a small company, Dr. Mulliez, orthopedie - Dr. Denys, geriatrie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 665,771.

Dr. Mulliez, orthopedie - Dr. Denys, geriatrie (Private Limited)

Dossier Dr. Mulliez, orthopedie - Dr. Denys, geriatrie, printed on 1 October 2026 from databakkes.be/en/0674965095/dr-mulliez-orthopedie-dr-denys-geriatrie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Mulliez, orthopedie - Dr. Denys, geriatrie from Aalst, company number BE0674965095, closed financial year 2025 with a result of € 472,460 after tax. For that financial year Dr. Mulliez, orthopedie - Dr. Denys, geriatrie recorded a gross margin of € 665,771 and equity of € 20,431. Compared with financial year 2024, the result moved from € 445,763 to € 472,460. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Healthy

€ 20,431

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 472,460

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 158,383

▲ 74% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 472,460 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 67,627

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 360

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,597

▲ 130% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 303,540 Gross margin 2022: € 303,540 First fiscal year in the series	€ 553,662 Gross margin 2023: € 553,662 ▲ 82% vs 2022 (€ 303,540) Favourable step	€ 622,565 Gross margin 2024: € 622,565 ▲ 12% vs 2023 (€ 553,662) Favourable step	€ 665,771 Gross margin 2025: € 665,771 ▲ 7% vs 2024 (€ 622,565) Favourable step	▲ 7%
Profit after taxes	€ 217,629 Profit after taxes 2022: € 217,629 First fiscal year in the series	€ 405,986 Profit after taxes 2023: € 405,986 ▲ 87% vs 2022 (€ 217,629) Favourable step	€ 445,763 Profit after taxes 2024: € 445,763 ▲ 10% vs 2023 (€ 405,986) Favourable step	€ 472,460 Profit after taxes 2025: € 472,460 ▲ 6% vs 2024 (€ 445,763) Favourable step	▲ 6%
Equity	€ 238,060 Equity 2022: € 238,060 First fiscal year in the series	€ 20,431 Equity 2023: € 20,431 ▼ 91% vs 2022 (€ 238,060) Unfavourable step	€ 20,431 Equity 2024: € 20,431 Unchanged (€ 20,431) Unchanged	€ 20,431 Equity 2025: € 20,431 Unchanged (€ 20,431) Unchanged
Total debts	€ 9,094 Total debts 2022: € 9,094 First fiscal year in the series	€ 446,900 Total debts 2023: € 446,900 ▲ € 437,806 vs 2022 (€ 9,094) Unfavourable step	€ 287,908 Total debts 2024: € 287,908 ▼ 36% vs 2023 (€ 446,900) Favourable step	€ 331,779 Total debts 2025: € 331,779 ▲ 15% vs 2024 (€ 287,908) Unfavourable step	▲ 15%
Cash	€ 98,601 Cash 2022: € 98,601 First fiscal year in the series	€ 366,984 Cash 2023: € 366,984 ▲ 272% vs 2022 (€ 98,601) Favourable step	€ 91,122 Cash 2024: € 91,122 ▼ 75% vs 2023 (€ 366,984) Unfavourable step	€ 158,383 Cash 2025: € 158,383 ▲ 74% vs 2024 (€ 91,122) Favourable step	▲ 74%
Retained profit	€ 218,060 Retained profit 2022: € 218,060 First fiscal year in the series	€ 431 Retained profit 2023: € 431 ▼ € 217,629 vs 2022 (€ 218,060) Unfavourable step	€ 431 Retained profit 2024: € 431 Unchanged (€ 431) Unchanged	€ 431 Retained profit 2025: € 431 Unchanged (€ 431) Unchanged
Dividend	€ 1,334,852 Dividend 2022: € 1,334,852 First fiscal year in the series	€ 623,616 Dividend 2023: € 623,616 ▼ 53% vs 2022 (€ 1,334,852) Unchanged	€ 445,763 Dividend 2024: € 445,763 ▼ 29% vs 2023 (€ 623,616) Unchanged	€ 472,460 Dividend 2025: € 472,460 ▲ 6% vs 2024 (€ 445,763) Unchanged	▲ 6%
Balance sheet total	€ 247,154 Balance sheet total 2022: € 247,154 First fiscal year in the series	€ 467,331 Balance sheet total 2023: € 467,331 ▲ 89% vs 2022 (€ 247,154) Unchanged	€ 308,339 Balance sheet total 2024: € 308,339 ▼ 34% vs 2023 (€ 467,331) Unchanged	€ 352,210 Balance sheet total 2025: € 352,210 ▲ 14% vs 2024 (€ 308,339) Unchanged	▲ 14%

Key figures of Dr. Mulliez, orthopedie - Dr. Denys, geriatrie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Mulliez, orthopedie - Dr. Denys, geriatrie?

What happened at Dr. Mulliez, orthopedie - Dr. Denys, geriatrie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 472,460 (▲ 6% vs 2024). Source: NBB ↗
May 1, 2017 New establishment in Aalst. KBO
May 1, 2017 Start of the company according to the CBE. KBO
2017 Katrien Denys became a director. NBB
2017 Alexander Mulliez became a director. NBB

In short

From € 217,629 profit in 2022 to € 472,460 profit in 2025.

Paid € 502,298 in corporate taxes since 2022.

Best year ever: 2025, with € 472,460 profit.

Paid out € 2.9 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Mulliez, orthopedie - Dr. Denys, geriatrie? We notify you, reason included.

Follow Dr. Mulliez, orthopedie - Dr. Denys, geriatrie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Katrien Denys Alexander Mulliez

Dr. Mulliez, orthopedie - Dr. Denys, geriatrie

ORTHOPEDIE-TRAUMATOLOGIE AZORG

Behind Dr. Mulliez, orthopedie - Dr. Denys, geriatrie are Katrien Denys and Alexander Mulliez. Alexander Mulliez is also behind ORTHOPEDIE-TRAUMATOLOGIE AZORG.

See the full network in the app

Directors

According to the 2025 annual accounts

Katrien Denys

Director

since 2017

Alexander Mulliez

Director

Also active at: ORTHOPEDIE-TRAUMATOLOGIE AZORG

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Horingstraat 13

9310 Aalst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0674.965.095
VAT number: BE 0674.965.095
Registered office: Horingstraat 13, 9310 Aalst
Names & denominations: Dr. Mulliez, orthopedie - Dr. Denys, geriatrie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 May 2017
Peppol: Active · Active since 19 Oct 2024

View on CBE Public ↗ Annual accounts (NBB) ↗